DESCRIPTION

RotaTeq is a live, oral vaccine that contains five reassortant rotaviruses developed from human and bovine parent rotavirus strains.

RotaTeq consists of the five human–bovine reassortants suspended in a solution of buffer (sodium citrate and phosphate) and stabilizer (sucrose). Each 2-mL vial of vaccine contains approximately 2 x 106 infectious units of each of the five reassortant strains. The vaccine formulation contains sucrose, sodium citrate, sodium phosphate monobasic monohydrate, sodium hydroxide, polysorbate 80, and tissue culture media. Trace amounts of fetal bovine serum might be present. The vaccine contains no preservatives or thimerosal.

The duration of immunity from rotavirus vaccine is not known.